MIRA INFORM REPORT
|
Report Date : |
12.01.2012 |
IDENTIFICATION DETAILS
|
Correct Name : |
RANBAXY FARMACÊUTICA LTDA |
|
|
|
|
Registered Office : |
Av Eugenio Borges,1060 Parte - Arsenal, Zip Code 24751-000 - São Gonçalo/Rj |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Date of Incorporation : |
27.10.1993 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Brazil |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name
RANBAXY
FARMACÊUTICA LTDA
company ADDRESSES
|
MAIN ADDRESS: |
AV EUGENIO BORGES,1060 PARTE - ARSENAL |
|
ZIP CODE/CITY: |
24751-000 - SÃO GONÇALO/RJ |
|
|
|
|
PHONE: |
21 3605-2406 |
|
FAX: |
21 3605-2406 |
|
E-MAIL: |
|
|
WEB SITE: |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
AV MARIA COELHO AGUIAR,215 ANDAR 8, BLOCO A, PARTE - JARDIM SAO LUIZ |
|
ZIP CODE/CITY: |
05804-900 SÃO PAULO/SP |
|
PHONE: |
11 5189-9735 |
|
FAX: |
11 5189-9735 |
|
CNPJ: |
73.663.650/0003-52 |
LEGAL DATA
|
MAIN ACTIVITIES: |
|
MANUFACTURE OF PHARMACEUTICAL. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
27/10/1993 |
|
REGISTER DATE: |
27/10/1993 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
73.663.650/0001-90 |
|
STATE REGISTER: |
85.396.757 |
|
|
|
|
SHARE CAPITAL: |
R$ 17.366.914,00 |
|
LAST REGISTER OF CAPITAL: |
31/01/2011 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
ALOK SHUBHKAR KAPOOR |
DIRECTOR |
|
ANATHAN SETHURAMAN |
DIRECTOR |
AUTHORIZED USE OF SIGNATURE
|
THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
RANBAXY (NETHERLANDS) B.V. |
R$ 17.366.913,00 |
|
RANBAXY HOLDINGS UK LIMITED |
R$ 1,00 |
|
AFFILIATES / SUBSIDIARIES: |
|
|
|
|
|
NOT AVAILABLE |
|
COMPANY'S BACKGROUND
|
THE SUBJECT WAS ESTABLISHED ON OCTOBER 27, 1993 AS DAVIDSON QUIMICA E
FARMACÊUTICA LTDA. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON JULY 13, 2001 IT ADOPTED THE NAME RANBAXY SP MEDICAMENTOS
LTDA. AND LATER IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE IT IS
STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN. THE COMPANY OPERATES WITH THE TRADE NAME "RANBAXY". BUSINESS ADDRESS HAS CHANGED FROM (RUA ALEXANDRE DUMAS, 2220 - SÃO
PAUL/SP) TO THE PRESENT REGISTERED ONE. FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY IS SO FAR NOT KNOWN. REMARKS: -------- WHEN INTERVIEWED SOURCES AT THE SUBJECT STATED THAT ARE STILL WAITING FOR
AUTHORIZATION FROM THE PRINCIPALS TO PROVIDE THE DATA NECESSARY TO COMPLETE
THIS REPORT. A REQUEST FOR FURTHER DATA HAS BEEN SENT TO THE COMPANY. PROVIDED THE
DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY REPORT WILL BE
SENT TO YOUR ATTENTION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
|
PUBLIC RECORDS
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
FINANCIAL INFORMATION
|
DUE TO THE SUBJECT'S LEGAL FORM, IT IS NOT OBLIGED TO PUBLISH THE
BALANCE SHEET INFORMATION. WHEN INTERVIEWING SOURCES AT THE SUBJECT COMPANY
DECLINED TO PROVIDE ANY KIND OF FINANCIAL INFORMATION AS THEY ARE STILL NOT
AUTHORIZED TO DO SO. OUR INVESTIGATION THROUGH THE OUTSIDE SOURCES SHOWED NO FINANCIAL DATA
ABOUT THE SUBJECT. |
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 1,80 |
- OFFICIAL RATE ON 10/01/2012 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
IN THE ABSENCE OF FINANCIAL DATA NO COMMENTS CAN BE PROVIDED ABOUT THE
COMPANY'S CURRENT FINANCIAL STANDING. |
|
REAL ESTATE: |
NOT AVAILABLE
|
VEHICLES: |
NOT AVAILABLE
|
MACHINES: |
NOT AVAILABLE
INSURANCE
|
NOT AVAILABLE |
BANKING REFERENCES
|
NOT AVAILABLE |
|
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE
ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK
OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN
THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). |
ACTIVITIES COMMENTS
|
MANUFACTURE OF PHARMACEUTICAL. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
NOT AVAILABLE |
EXPORTS TO:
|
NOT AVAILABLE |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
|
|
NOT AVAILABLE |
|
|
|
STAFF: |
|
|
|
NOT AVAILABLE |
CONCEPT AND FULFILMENT
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1993. SO FAR
IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOUR. THE COMPANY HAS TRADE RELATIONS WITH SOME SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
|
|
NOT AVAILABLE |
|
|
|
PAYMENT HISTORY: |
|
3 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 59.993,00 |
|
|
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 58.456,00 |
|
HIGHEST CREDIT: R$ 58.456,00 |
FINAL OPINION
|
BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR
NORMAL BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON FULLY
SECURED TERMS ONLY DUE TO THE ABSENCE OF FINANCIAL DATA. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.75 |
|
UK Pound |
1 |
Rs.80.01 |
|
Euro |
1 |
Rs.65.99 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.